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Avian bornavirus (ABV) is a newly discovered mem-
ber of the family Bornaviridae that has been associated with 
the development of a lethal neurologic syndrome in birds, 
termed proventricular dilatation disease (PDD). We suc-
cessfully isolated and characterized ABV from the brains 
of 8 birds with conﬁ  rmed PDD. One isolate was passed 6 
times in duck embryo ﬁ  broblasts, and the infected cells were 
then injected intramuscularly into 2 healthy Patagonian 
conures (Cyanoliseus patagonis). Clinical PDD developed 
in both birds by 66 days postinfection. PDD was conﬁ  rmed 
by necropsy and histopathologic examination. Reverse 
transcription–PCR showed that the inoculated ABV was in 
the brains of the 2 infected birds. A control bird that received 
uninfected tissue culture cells remained healthy until it was 
euthanized at 77 days. Necropsy and histopathologic ex-
aminations showed no abnormalities; PCR did not indicate 
ABV in its brain tissues.
P
roventricular dilatation disease (PDD) is a progressive, 
invariably fatal neurologic disease that has been report-
ed for >50 species of psittacine birds as well as many other 
bird species (1). It is considered a serious disease because 
many of these birds are highly endangered, and several af-
fected species depend on captive breeding for their survival. 
The clinical signs of PDD vary and may be predominately 
neurologic (weakness, ataxia, proprioceptive deﬁ  cits, sei-
zures, blindness), gastrointestinal (weight loss, passage of 
undigested food, regurgitation, delayed crop emptying), or 
a combination thereof (2). The gastrointestinal signs, espe-
cially proventricular dilatation, are secondary to pseudo-
obstruction brought about by damage to the enteric nervous 
system. PDD is characterized by severe lymphoplasmacyt-
ic inﬂ  ammation in peripheral, central, and autonomic ner-
vous tissues (3–5). Deﬁ  nitive diagnosis of PDD requires 
demonstration of lymphoplasmacytic ganglioneuritis in the 
intestinal tract. 
Recently, 2 independent groups of investigators identi-
ﬁ  ed a new member of the family Bornaviridae, named avian 
bornavirus (ABV), in parrots with histopathologically con-
ﬁ  rmed PDD. Honkavuori et al. used unbiased high-through-
put sequencing to identify the virus in several parrots with 
histopathologically conﬁ  rmed PDD (6). Quantitative PCR 
conﬁ  rmed the presence of the virus in brain, proventriculus, 
and adrenal gland in 3 birds with PDD but not in 4 unaffect-
ed birds. Kistler (7) used a panviral microarray to identify a 
bornavirus hybridization signature in 5 of 8 birds with PDD 
and 0  of 8 controls. These investigators used ultra high-
throughput sequencing combined with conventional PCR-
based cloning to recover a complete viral genome sequence. 
Before this discovery, the family Bornaviridae contained 
only 1 species, Borna disease virus (BDV). BDV causes 
a neurologic syndrome, Borna disease, which is restricted 
to central Europe, where it is found primarily in horses and 
sheep. The virus infects neurons and astrocytes, and the re-
sulting disease appears to be mediated by an immunopatho-
logic response of the host to the virus. 
BDV can be grown in mammalian cell culture, where 
it causes a noncytolytic persistent infection. Borna disease 
appears as a sporadic infection affecting small numbers of 
animals each year. Its epidemiology is unclear, but it may 
be carried by certain species of shrews (8). BDV has also 
been detected in the feces of wild birds and in captive os-
triches, but the epidemiologic signiﬁ  cance of this observa-
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tion is unclear (9,10). Studies undertaken in this laboratory 
have demonstrated some histopathologic similarities, in 
particular in the selective destruction of cerebellar Purkinje 
cells, between ABV and BDV infections of the brains of 
birds and mammals, respectively (11).
Seven ABV genotypes have been identiﬁ  ed based on 
partial genome sequencing (12,13). In general, these ABV 
strains show only ≈65% sequence identity with BDV. Nev-
ertheless, the overall structure of the bornaviral genome is 
well conserved (6,7). Thus, the number and order of genes 
is unchanged, as is the structure of transcription initiation 
and termination sites. Recently, Rinder et al. (14) have 
shown that the region between the N and X gene in ABV 
is shorter than that in BDV. ABV apparently lacks a 22-
nt fragment that serves a regulatory function for the genes 
coding for viral proteins X and P.
Although these discoveries suggest that ABV is a 
plausible cause of PDD, as described in Koch’s postulates, 
proof of a causal relationship requires isolation of the agent 
from infected birds; its propagation in culture; and, after 
reintroduction of the isolate into a susceptible host, mani-
festation of the disease (15). We describe the isolation and 
culture of ABV from the brains of 8 psittacine birds with 
histopathologically conﬁ  rmed PDD. After 6 passages, 1 
of the cultured isolates was intramuscularly injected into 
2 healthy Patagonian conures (Cyanoliseus patagonis). 
Typical PDD subsequently developed in each bird, and the 
inoculated virus was found in the brain.
Materials and Methods
Parrots
From independent sources we obtained 8 parrots that 
had clinical signs of PDD, were clinically judged to be in 
the late stages of the disease, and were euthanized for hu-
mane reasons. The 8 birds were 1 green-winged macaw 
(Ara chloroptera), 1 scarlet macaw (A. macao), 2 blue and 
yellow macaws (A. ararauna), 2 yellow-collared macaws 
(Primolius auricollis), 1 African gray parrot (Psittacus er-
ithracus), and 1 umbrella cockatoo (Cacatua alba). Four 
parrots with conditions not related to PDD and euthanized 
for humane reasons were also included in the study as neg-
ative controls.
Necropsy
Immediately after euthanasia, complete necropsies 
were performed on all birds. Tissue samples from brain, 
spinal cord, peripheral nerves, lungs, heart, liver, spleen, 
pancreas, adrenal glands, kidneys, crop, proventriculus, 
ventriculus, intestine, and cloaca were placed in 10% buff-
ered formalin for histopathologic examination. Tissue sec-
tions were stained with hematoxylin and eosin to conﬁ  rm 
the clinical diagnosis. Half of each brain was retained for 
virus isolation, Western blot, and reverse transcription–
PCR (RT-PCR).
Tissue Culture
Speciﬁ  c pathogen–free duck eggs were obtained from 
the US Department of Agriculture Avian Disease Labora-
tory (East Lansing, MI, USA). Embryos 9–10 days old were 
harvested, macerated, and cultured. Primary duck embryonic 
ﬁ  broblasts (DEFs) were used for virus isolation and propa-
gation. DEFs were maintained in Leibowitz L15–McCoy 
5A medium (LM; Sigma-Aldrich, St. Louis, MO, USA) 
supplemented with 5% bovine calf serum (Sigma-Aldrich) 
and 1% penicillin-streptomycin at 37°C in an atmosphere of 
5% CO2. DEFs were seeded to conﬂ  uency 24 h before in-
oculation. DEFs not inoculated with tissue homogenate were 
maintained in parallel throughout the experiment.
Virus Isolation and Culture
Brain tissue was harvested immediately after eutha-
nasia. Sections of the cerebrum and cerebellum were ho-
mogenized, minced, and then passed through an 18-gauge 
needle in LM complete medium. In instances where im-
mediate culture inoculation was not possible, the brain tis-
sue was frozen at –80°C within minutes of being harvested 
and was thawed in a 37°C water bath immediately before 
inoculation. One milliliter of the brain suspension was used 
to inject previously plated DEF monolayers that were then 
incubated for 24 h. The injected DEF cultures were then 
washed once with phosphate-buffered saline (PBS), re-
placed with fresh LM medium supplemented with 2% fetal 
calf serum, and incubated for 5–7 days. Infected DEFs were 
trypsinized and cocultivated with freshly plated DEFs. This 
procedure was repeated for a minimum of 3 passages.
Western Blot Analysis
Infected DEFs passaged a minimum of 3 times were 
used for Western blot analyses. Samples from infected 
DEFs were collected by trypsinization and pelleted by cen-
trifugation, and pellets resuspended in PBS were sonicated 
on ice at 50% intensity for 5 min (Soniﬁ  er 250; Branson 
Ultrasonics Corp, Danbury, CT, USA); 50% intensity). 
Western blotting was performed as described by Towbin 
et al. (16) by using 10% polyacrylamide gels and a Mini-
Protean II gel electrophoresis apparatus (Bio-Rad, Hercu-
les, CA, USA). The tissue culture preparations were diluted 
in sample loading buffer containing β-mercaptoethanol at 
a ratio of 1:1 and heated to 95°C for 5 min before being 
loaded (30 μg/slot). A prestained sodium dodecyl sulfate–
polyacrylamide gel electrophoresis standard covering the 
6.5- to 200-kDa range was used for molecular weight esti-
mation (Bio-Rad).
The size-fractionated antigen preparations were trans-
ferred to Immobilon polyvinylidene ﬂ  uoride transfer mem-
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branes (Millipore, Bedford, MA, USA) as described by 
Towbin et al. (16). Transfer efﬁ  ciency was indicated by 
the presence of prestained bands on the membranes. After 
transfer, the membranes were incubated for 2 h in PBS, 
0.05% Tween-20, 3% skimmed milk (PBST blocking buf-
fer), then with histopathologically conﬁ  rmed PDD-positive 
parrot serum diluted 1:5,000 in PBST blocking buffer for 
2 h and with horseradish peroxidase–conjugated goat anti-
macaw immunoglobulin Y (Bethyl Inc., Montgomery, TX, 
USA) diluted 1:10,000 in PBST blocking buffer for 1 h. 
Membranes were washed with PBST after each step, and 
all steps were performed at room temperature under con-
stant shaking. Finally, the membranes were incubated for 
30 min in Sigma-Fast 3,3′-diaminobenzidine developing 
substrate (Sigma-Aldrich) and then rinsed in distilled wa-
ter. The serum from a conﬁ  rmed PDD-positive parrot used 
in this experiment has been shown to contain antibodies 
speciﬁ  c for the 38-kDa ABV N-protein by its reaction with 
2 preparations of recombinant protein prepared in Escheri-
chia coli and in mammalian cell systems (11).
Indirect Immunoﬂ  uorescent Assay 
Infected DEF were washed 2 times for 5 min each in 
0.02M PBS, ﬁ  xed for 10 min in 2% paraformaldehyde in 
0.02 M PBS, and washed 2 times for 5 min each in 0.02 M 
PBS. Cells were permeabilized in 1% Triton X-100/0.02 
M PBS for 10 min and washed 3 times for 5 min each in 
0.3% Tween/0.02 M PBS. Blocking was performed for 2 h 
in 5% dried milk/0.3% Tween/0.02 M PBS. The cells were 
incubated in a humidiﬁ  ed chamber for 30 min at 37°C with 
the primary antibody (serum from a parrot with histopatho-
logically conﬁ  rmed PDD) at a 1:500 dilution in 1% dried 
milk/0.3% Tween/0.02 M PBS. Cells were washed 3 times 
for 5 min each in 0.03% Tween/0.02 M PBS. The cultures 
were then incubated in a humidiﬁ  ed chamber for 30 min at 
37°C with the secondary antibody (horseradish peroxidase– 
or ﬂ  uorescein isothiocyanate–conjugated goat anti-macaw 
immunoglobulin G; Bethyl Inc.) at a 1:500 dilution in 1% 
dried milk/0.3% Tween/0.02M PBS. Cells were washed 3 
times for 5 min each in 0.03% Tween/0.02M PBS and then 
rinsed in distilled water and mounted with ProLong anti-
fade reagent with DAPI (Invitrogen, Carlsbad, CA, USA).
RT-PCR
Total RNA was isolated from collected brain tissue 
and passaged DEF by using the RNeasy Mini Kit (QIA-
GEN, Valencia, CA, USA). First-strand cDNA was gener-
ated by using the High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems, Foster City, CA, USA), with 
1μg RNA and random primers. PCR for ABV N-protein 
was performed by using 1–2 μL cDNA and forward (5F: 
5′-GCGGTAACAACCAACCAGCAA3-′) and reverse 
(1212R: 5′-GTTCATTAGTTTGCRAATCCRGTTA3-′) 
primers, which were developed using GenBank submissions 
NC_001607.1, FJ169441.1, and FJ169440.1 for reference. 
Ampliﬁ  cation conditions were as follows: 1 cycle at 94°C 
for 2 min; 35 cycles at 94°C for 30 sec, 50°C for 30 sec, 
and 72°C for 80 sec; ﬁ  nal extension at 72°C for 7 min. PCR 
products were cloned in TOPO-TA vector (Invitrogen), and 
individual clones were sequenced after transformation into 
E. coli. DNA sequencing reactions were performed by us-
ing the ABI BigDye Terminator Cycle Sequencing Kit, and 
sequences were generated with an ABI PRISM 3100 Ge-
netic Analyzer (Applied Biosystems). Sequences were as-
sembled and aligned by using Geneious Pro 4.6.2 software 
(www.geneious.com). Isolates were assigned to previously 
deﬁ  ned ABV groups by comparing a 397-nt region to se-
quences representing avian bornaviruses 1–5 (GenBank 
accession nos. FJ002329, FJ603688, FJ002328, FJ603687, 
FJ002335). Evolutionary distances were computed by us-
ing a Kimura 2-parameter model with MEGA4 software 
(www.megasoftware.net).
Experimental Infections
Experimental infections were performed under Animal 
Use Protocol no. 2009–033B approved by the Texas A&M 
University Institutional Animal Care and Use Committee. 
Three adult Patagonian conures were shown to be serone-
gative by Western blotting and to be ABV negative by fe-
cal PCR. All 3 birds were known to be chronic carriers of 
psittacine herpes virus; 1 had a cloacal papilloma, but all 
were otherwise in good health. Psittacine herpes virus has 
never been implicated in PDD. Two birds were placed in 
isolation and inoculated by intramuscular injection with in-
fected DEFs containing 8 × 104 focus-forming units (17) of 
an ABV4 (M24) originally isolated from a yellow-collared 
macaw. A large batch of the M24 strain was grown for 5 
days on passage 6, and 500-μL aliquots of this batch were 
frozen at –80°C in freezing medium. Two of the 500-μL 
aliquots were grown for 5 days, and immunohistostaining 
(by using the immunoﬂ  uorescent antibody [IFA] assay de-
scribed, substituting the ﬂ  uorescein isothiocyanate–labeled 
antibodies with horseradish peroxidase–labeled antibodies) 
was used to visualize and quantify the focus-forming units.
Results
Isolation and Culture of Avian Bornavirus Isolates
Cytopathic effects were not observed in any of the 12 
DEF cultures inoculated with brain tissue harvested from 
birds with or without clinical signs of PDD. Western blot 
analyses showed a pronounced ABV N-protein band in ex-
tracts of 8 of the 12 cultures. Only DEF cultures inoculated 
with samples from parrots displaying histopathologically 
conﬁ  rmed PDD were positive by Western blotting (Figure 1). 
ABV N-protein was not detectable in the 4 cultures injected 
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with brain tissue from birds with no histologic evidence of 
PDD. IFA of infected DEFs also demonstrated ABV N-pro-
tein within cells. Foci of antigen-positive cells were appar-
ent 3 days after culture inoculation. Many cells showed both 
nuclear and diffuse cytoplasmic staining. Other cells showed 
the characteristic punctate nuclear staining of infected cul-
tures (Figure 2). No positive immunoﬂ  uorescence was ob-
served in uninfected DEFs or in DEFs inoculated with brain 
tissue from negative control birds.
Characterization of Avian Bornavirus Isolates
RNA was isolated from the brain tissues and infected 
DEF cultures of 8 parrots with PDD and 4 parrots that were 
PDD negative. A 397-bp region of the ABV N-gene was 
ampliﬁ  ed from all 8 PDD brain and tissue culture samples 
but not those from the 4 negative parrots. The amplicons 
were cloned and their sequences compared with previously 
described ABV groups (7). One isolate, M25, was most 
closely related to ABV group 1, whereas the other 7 ABV 
isolates were most closely related to ABV group 4 (Table). 
Pairwise comparisons among the group 4 isolates ranged 
from 94.2% to 99.7% nucleotide identity. When 2–3 com-
plete N-protein gene sequences (1,143 nt) originating from 
any bird were compared, nucleotide sequence identity 
ranged from 99.2% to 100% (data not shown).
Experimental Infections
Two Patagonian conures were challenged with ABV4, 
strain M24. They were tested by fecal PCR before challenge 
and at 33, 43, 60, and 62 days postchallenge. Both conures 
were seronegative by Western blotting before challenge but 
seropositive for antibodies to the 38-kDa N-protein on day 
33 and thereafter. Fecal PCR testing showed that both birds 
were negative on days 33 and 43. One bird was weakly 
positive on day 60, but both were strongly positive on day 
62. One inoculated bird died on day 66. Necropsy showed 
a dilated proventriculus and gross lesions characteristic of 
PDD. Subsequent histopathologic examination conﬁ  rmed 
that the bird had a lymphoplasmacytic ganglioneuritis typi-
cal of PDD in the crop, proventriculus, gizzard, and intes-
tine (Figure 3). This gangloneuritis included mild to severe 
inﬁ  ltration of lymphocytes and a few plasma cells in the 
serosa, subserosal nerves, and ganglia. The bird also had 
adrenalitis, encephalitis, and neuritis, as well as a myo-
carditis. The heart showed a lymphocytic inﬁ  ltration of the 
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Figure 1. Western blot of infected duck embryonic ﬁ  broblasts 
(DEFs) showing avian bornavirus N-protein during culture. Lanes 
1–4 are supernatant ﬂ  uids. Lane I is from an African gray parrot 
(AG5).  Lanes 2 and 3 are from a yellow-collared macaw (M24). 
Lane 4 is from uninfected DEFs. Lanes 5–8 are sonicated cell 
extracts. Lane 5 from AG5; 6 and 7 from M24; and Lane 8 from 
uninfected DEFs. Lane 9 is an infected brain control. The virus is 
strongly cell associated.
Figure 2. A) Avian bornavirus (ABV)–infected duck embryonic 
ﬁ   broblast (DEF) cell culture 6 days after injection with 
hindbrain tissues from an African gray parrot with conﬁ  rmed 
proventricular dilatation disease (AG5) and staining by an 
indirect immunoﬂ  uorescence assay for ABV N-protein. Speckled 
immunoﬂ   uorescence is typical of bornavirus infection. Original 
magniﬁ  cation ×40. B) DEFs 3 days after injection with forebrain 
from a yellow-collared macaw with conﬁ  rmed  proventricular 
dilatation disease (M24). Nuclear and cytoplasmic ﬂ  uorescence in 
DEFs stained by immunoﬂ  uorescence assay for ABV N-protein. 
Original magniﬁ  cation ×40.Propagation of Avian Bornavirus
epicardial ganglia as well as in and around Purkinje ﬁ  bers. 
Thus, the brain and spinal cord showed multifocal perivas-
cular cufﬁ  ng and gliosis (Figure 4). The adrenal medulla 
was inﬁ  ltrated with lymphocytes and plasma cells. 
The second inoculated bird was examined on day 66 
and was found to be emaciated and had clinical signs con-
sistent with PDD. It was euthanized for humane reasons. 
This bird also had gross and histopathologic lesions char-
acteristic of PDD, essentially identical to those described 
above. The brains of both conures were subjected to PCR 
for ABV N-protein as described above. Results for both 
were positive (Figure 5). Sequence analysis of the PCR 
products conﬁ  rmed that bird brains contained ABV4 iden-
tical to the M24 challenge strain. Brain homogenates from 
these 2 birds were also cultured on DEFs, and a strong posi-
tive PCR signal was obtained at day 16 of culture. 
The third conure in this study received uninfected 
DEFs by both intramuscular and oral routes as described 
for experimentally infected birds. This bird was housed in 
an aviary separate from the isolation facilities of the infect-
ed birds. It was in apparent good health when euthanized 
on day 77. Necropsy of the bird conducted, including his-
topathologic examination of its tissues, and PCR was per-
formed on 4 regions of its brain. No evidence of PDD was 
seen during necropsy or histopathologic examination, and 
all 4 brain samples were negative for ABV nucleic acid.
Discussion
Although it has long been proposed that a viral patho-
gen was responsible for PDD, past attempts to identify a 
causal agent through inoculation of chick embryos and a 
variety of tissue cultures were unsuccessful. Because no 
cytopathic effects were detected in the DEF cultures af-
ter several passages, prior attempts to grow the agent may 
have been successful but had not been recognized because 
of lack of immunologic or PCR detection tools. We were 
able to isolate and propagate ABV from all studied birds 
with clinical PDD. IFA of infected DEF using this same an-
tiserum showed the punctate nuclear staining that is typical 
of cells infected with bornaviruses and appears to be the re-
sult of the formation of N-and P-protein complexes known 
as Joest-Degen inclusion bodies (18–20). It is noteworthy 
that we were unable to grow ABV in primary chicken em-
bryo ﬁ  broblasts handled the same as the DEFs. Rinder et 
al. reported successful propagation of ABV in the chicken 
LMH hepatoma cell line (14). However, they noted slow 
growth and only a few positive cells compared with propa-
gation in the quail ﬁ  broblast cell line CEC32 and the quail 
skeletal muscle cell line QM7. Thus ABV appears to have 
constraints in host cell range. PDD in chickens has not been 
reported. Rinder et al., like ourselves (P. Gray et al., unpub. 
data), were unable to grow ABV in cell lines of mammalian 
origin, such as Vero cells or MDCK cells in which BDV 
grows routinely. This research ﬁ  nding suggests that ABV 
may be unable to infect mammals. 
Bornavirus has a nonsegmented negative strand ge-
nome. It encodes at least 6 proteins: N, X, P, M, G ,and L. 
The N or nucleoprotein interacts with the viral RNA and 
accumulates in the nucleus during the life cycle of the vi-
rus (21,22). The nucleoprotein of BDV exists in 2 isoforms 
of 40 and 38 kDa (23,24). P40 is primarily nuclear, and 
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Table. Percent nucleotide identity between partial N genes in avian bornavirus isolates 
Gene ABV Type 1a*  M25 M20 AG5 M15 M10 M14 M24 06 ABV Type 4b† 
ABV Type 1a  100.0
 M25  89.4 100.0
 M20  80.9 82.0 100.0
 AG5  80.9 82.0 99.7 100.0
 M15  80.9 82.0 99.9 99.7 100.0
 M10  80.9 82.0 99.6 99.5 99.7 100.0
 M14  81.1 81.7 99.6 99.6 99.7 99.6 100.0
 M24  81.1 81.7 95.0 94.8 94.7 94.5 94.5 100.0
 06  81.4 81.8 94.5 94.5 94.4 94.3 94.2 99.3 100.0
ABV Type 4b  80.6 81.4 94.0 94.7 94.7 94.7 95.0 92.7 94.5 100.0
*ABV genotype 1 accession no. FJ002329. 
†ABV genotype 4 accession no. FJ603687. 
Figure 3. Proventriculus wall from conure PG8 showing 
characteristic lymphoplasmacytic inﬁ   ltration of the subserosal 
enteric ganglia as well as inﬁ  ltration of submucosa. This bird had 
been inoculated 55 days earlier with avian bornavirus, genotype 4. 
Original magniﬁ  cation ×325.RESEARCH
P38 is primarily cytoplasmic. Both isoforms can bind to 
the viral phosphoprotein. The immunoﬂ  uorescent staining 
pattern observed with ABV-infected DEFs, which showed 
a punctate nuclear staining combined with a more diffuse 
cytoplasmic staining, is thus compatible with the known 
properties of the BDV nucleoprotein. Of 8 isolates reported 
here, 7 were of genotype 4 and 1 was of genotype 1. This 
ﬁ  nding may suggest that genotype 4 is a more pathogenic 
type associated with disease, or it may simply be the pre-
dominant strain circulating in Texas.
Rinder et al. (14) reported on 6 isolates from Germa-
ny, 4 of which were genotype 4 and the others were geno-
type 2. This ﬁ  nding supports the suggestion that geno-
type 4 may be predominant worldwide and possibly more 
virulent than other genotypes. The experimental infection 
of 2 Patagonian conures with cultured virus that result-
ed in clinical PDD 66 days postinfection fulﬁ  lls Koch’s 
postulates. PCR and sequencing of the ampliﬁ  ed product 
demonstrated large amounts of ABV4 in the brains of the 
challenged birds. The birds did seroconvert for anti-N 
antibodies at 33 days, whereas fecal shedding was not 
detected until days 60–62. This ﬁ  nding is in contrast to 
observations on naturally infected birds in which fecal 
shedding may precede seroconversion by many months 
(25). ABV RNA was detected by RT-PCR after a mini-
mum of 3 passages in DEF primary cell culture subse-
quent to inoculation with brain tissue from all 8 necropsy-
conﬁ  rmed PDD-positive birds. PCR detection in the brain 
tissue and ready isolation of the virus from freshly har-
vested brain tissue are compatible with the concept that 
PDD originates as a viral encephalitis (11). 
Gancz et al. (26) have induced PDD in cockatiels 
(Nymphicus hollandicus) after inoculation of brain homo-
genates from PDD-affected, ABV-positive birds. Although 
the ﬁ  ndings of Gancz et al. support our results and are in 
line with previous ﬁ  ndings (27), interpretation of their re-
sults is difﬁ  cult because of evidence for an autoimmune 
component in PDD similar to that which occurs in Guillain 
Barré syndrome (28). We also have detected autoantibodies 
to myelin basic protein and other nervous system autoanti-
gens in PDD cases, suggesting that in this study, the brain 
homogenate may have contributed to the abnormalities ob-
served. (25). The known pathogenesis of mammalian bor-
navirus infections ﬁ  ts well with the causative role of ABV 
in PDD. Both PDD and mammalian Borna disease share 
many attributes, including a viral encephalitis and polyneu-
ritis with selective destruction of Purkinje cells, lympho-
cyte inﬁ  ltration, and dysfunction of the central, peripheral, 
and autonomic nervous systems (29–31).  
In conclusion, the results reported here together with 
previous  ﬁ  ndings  conﬁ   rm unequivocally that the long-
sought cause of proventricular dilatation disease is indeed 
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Figure 4. Lymphoplasmacytic encephalitis with multifocal peri-
vascular cufﬁ  ng in the cerebrum of conure PG8 inoculated 55 days 
earlier with avian bornavirus genotype 4. Original magniﬁ  cation 
×725.
Figure 5. PCR of avian bornavirus N-protein in different areas of 
the brains of A) 2 Patagonian conures (PG7 and PG8) inoculated 
55 days earlier with avian bornavirus–infected duck embryonic 
ﬁ  broblasts and B) control, uninfected bird, PG5. HB, hindbrain; FB, 
forebrain; MB, midbrain; Cerebr., cerebrum.Propagation of Avian Bornavirus
avian bornavirus. Investigations into this virus and the com-
plex disease that it causes may provide useful insights into 
the pathogenesis of mammalian Borna disease. The origin 
and epidemiology, as well and prevention and treatment, of 
this infection remain to be elucidated. 
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